logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12642777 B1

PDFFull Text
Date of Patent:
Jun. 02, 2026

Filed:

Mar. 23, 2021

Use of mitoxantrone preparation in preparation of drug for diagnosing and treating breast cancer

Applicants:

Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd, Shenzhen, CN;

Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd, Shenzhen, CN;

Inventors:

Jun Liu, Shenyang, CN;

Xun Li, Shenyang, CN;

Zhanao Yang, Shenzhen, CN;

Feina Tu, Shenzhen, CN;

Ning Chen, Shenzhen, CN;

Quanhua Huang, Shenzhen, CN;

Ge Pan, Shenzhen, CN;

Baolin Lai, Shenzhen, CN;

Weiwei Zhang, Shenzhen, CN;

Yijing Hu, Shenzhen, CN;

Yang Li, Shenzhen, CN;

Assignees:

SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD, Shenzhen, CN;

SHENZHEN CHINA RESOURCES GOSUN PHARMACEUTICALS CO., LTD, Shenzhen, CN;

Attorney:

JMB Davis Ben-David

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Heather undefined Dahlin

Int. Cl.
CPC ...
A61K 31/136 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/20 (2006.01); A61P 35/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/136 (2013.01); A61K 9/0019 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/20 (2013.01); A61P 35/04 (2018.01);
Abstract

The use of a mitoxantrone preparation in the preparation of a drug for diagnosing and treating breast cancer. Provided is the use of mitoxantrone and/or a pharmaceutically acceptable salt thereof in the preparation of a lymphatic tracer in a disease associated with breast resection. No local or systemic toxic and side effects are seen after local injection of the preparation, suggesting that the preparation has good tolerance, effectiveness and safety, which provides a new treatment idea for thoroughly curing breast cancer in a breast cancer patient.

Find Patent Forward Citations

Liu, Jun. (2026). Use of mitoxantrone preparation in preparation of drug for diagnosing and treating breast cancer (U.S. Patent No. 12642777). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12642777

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…